(Q70937780)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8576282%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

editorial

0 references

title

Paclitaxel in the management of ovarian cancer: what we know and what we have yet to learn (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8576282%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

1 reference

1 reference

M Markman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8576282%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

publication date

1 January 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8576282%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cancer Research and Clinical Oncology

14 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8576282%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

volume

122

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8576282%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8576282%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

page(s)

71-73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8576282%20AND%20SRC:MED&resulttype=core&format=json

Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion.

14 October 2019

cites work

1 reference

12 December 2020

Phase II study and long-term follow-up of patients treated with taxol for advanced ovarian adenocarcinoma

1 reference

12 December 2020

European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion

1 reference

12 December 2020

Dose-intense taxol: high response rate in patients with platinum-resistant recurrent ovarian cancer

1 reference

12 December 2020

1 reference

12 December 2020

Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms

1 reference

12 December 2020

Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines.

1 reference

12 December 2020

Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103.

1 reference

12 December 2020

Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol.

1 reference

12 December 2020

Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01226263

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8576282%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

1 reference